histidine has been researched along with fumagillin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lowther, WT; Matthews, BW; McMillen, DA; Orville, AM | 1 |
| Chang, YH; Griffith, EC; Liu, JO; Niwayama, S; Ramsay, CA; Su, Z | 1 |
| Folkers, G; Klein, CD | 1 |
3 other study(ies) available for histidine and fumagillin
| Article | Year |
|---|---|
The anti-angiogenic agent fumagillin covalently modifies a conserved active-site histidine in the Escherichia coli methionine aminopeptidase.
Topics: Aminopeptidases; Base Sequence; Binding Sites; Cyclohexanes; DNA Primers; Escherichia coli; Fatty Acids, Unsaturated; Histidine; Mass Spectrometry; Methionyl Aminopeptidases; Neovascularization, Pathologic; Protein Binding; Recombinant Proteins; Sesquiterpenes | 1998 |
Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
Topics: Amino Acid Sequence; Aminopeptidases; Animals; Anti-Bacterial Agents; Catalytic Domain; Cell Division; Cell Line; Cyclohexanes; Cysteine; Endothelium, Vascular; Fatty Acids, Unsaturated; Histidine; Humans; Metalloendopeptidases; Mutagenesis, Site-Directed; Neovascularization, Pathologic; Recombinant Proteins; Sesquiterpenes; Spodoptera; Transfection | 1998 |
Understanding the selectivity of fumagillin for the methionine aminopeptidase type II.
Topics: Amino Acid Sequence; Aminopeptidases; Angiogenesis Inhibitors; Binding Sites; Computer Simulation; Cyclohexanes; Escherichia coli; Fatty Acids, Unsaturated; Histidine; Humans; Metalloendopeptidases; Methionyl Aminopeptidases; Models, Chemical; Models, Molecular; Molecular Sequence Data; Sesquiterpenes; Static Electricity; Time Factors | 2003 |